How is biochemotherapy for skin cancer given?

Biochemotherapy (a combination of chemotherapy drugs and immunotherapy agents) for skin cancer patients involves the following:
  • The treatment will require an inpatient hospitalization of five to seven days for each course of therapy.
  • The treatment will be a combination of chemotherapy agents (cisplatin, dacarbazine, Velban) and immunotherapy agents (interleukin-2, interferon). Dacarbazine will be given intravenously (in a vein, IV) on day one of treatment only. Cisplatin and Velban will be given by IV once daily on days one through four. Interleukin-2 will be given as a continuous IV infusion on days one through four. Interferon will be given as a subcutaneous injection (shot under the skin) daily on days one through five.
  • Patients will be evaluated approximately two to three weeks after a course of therapy for response.
  • Additional courses of therapy may be offered depending on response and tolerance to treatment.

Continue Learning about Skin Cancer Treatment

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.